# Rpk Pharmaceuticals Inc - Inspection Records

Source: https://www.globalkeysolutions.net/companies/rpk-pharmaceuticals-inc/4fcc57aa-1dbd-44d8-859b-3754c50751af

> Inspection records and compliance data for Rpk Pharmaceuticals Inc in Union City, California. Access full analysis and detailed observations.

---

## Details

- Name: Rpk Pharmaceuticals Inc
- FEI Number: 2937511
- City: Union City
- State: California
- Country Name: United States
- Address Line 1: 3281 Whipple Rd
- Zip Code: 94587

## Related Documents

- [483 - Rpk Pharmaceuticals Inc - 2021-10-14](https://www.globalkeysolutions.net/records/483/rpk-pharmaceuticals-inc/ee539f9e-8088-44ee-9bc1-4548c62fb828) — source: FDA, date: October 14, 2021
- [FDA Inspection 1155217 - Rpk Pharmaceuticals Inc - 2021-10-14](https://www.globalkeysolutions.net/records/fda_inspections/rpk-pharmaceuticals-inc/29b04edb-3611-4cb7-836f-566da8a56f09) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 14, 2021
- [FDA Inspection 1081636 - Rpk Pharmaceuticals Inc - 2019-02-28](https://www.globalkeysolutions.net/records/fda_inspections/rpk-pharmaceuticals-inc/32fb44df-9b7a-445b-9b2e-fd6c48437eec) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 28, 2019
- [483 - Rpk Pharmaceuticals Inc - 2019-02-25](https://www.globalkeysolutions.net/records/483/rpk-pharmaceuticals-inc/b07f1920-c28f-4f7f-b39f-845b70b9bbcc) — source: FDA, date: February 25, 2019
- [FDA Inspection 771926 - Rpk Pharmaceuticals Inc - 2012-03-08](https://www.globalkeysolutions.net/records/fda_inspections/rpk-pharmaceuticals-inc/e780fe8e-5ff4-4a18-91b8-4e47c32f5d1a) — classification: No Action Indicated (NAI), source: FDA, date: March 8, 2012
- [FDA Inspection 660576 - Rpk Pharmaceuticals Inc - 2010-04-09](https://www.globalkeysolutions.net/records/fda_inspections/rpk-pharmaceuticals-inc/e0cce943-b8eb-4be0-879e-6b807473056f) — classification: No Action Indicated (NAI), source: FDA, date: April 9, 2010
- [FDA Inspection 603965 - Rpk Pharmaceuticals Inc - 2009-08-07](https://www.globalkeysolutions.net/records/fda_inspections/rpk-pharmaceuticals-inc/8ee254b1-ebe4-49cc-9c2b-56927d1355d4) — classification: No Action Indicated (NAI), source: FDA, date: August 7, 2009

## Related Companies

- [Fujifilm Corporation](https://www.globalkeysolutions.net/companies/fujifilm-corporation/6310bc48-89ef-4f36-98c9-1e0294a89e06)
- [Meditco, Inc. D.B.A. Phoenicia Specialty Foods](https://www.globalkeysolutions.net/companies/meditco-inc-dba-phoenicia-specialty-foods/4296281d-f772-4072-b1de-c83a12281fe2)
- [Utah Cord Bank LLC](https://www.globalkeysolutions.net/companies/utah-cord-bank-llc/743c0464-dbbc-49bb-aa26-68e0f9dc8db6)
- [Xinxiang Tuoxin Pharmaceutical Co. Ltd](https://www.globalkeysolutions.net/companies/xinxiang-tuoxin-pharmaceutical-co-ltd/ba373358-5a25-46e6-a497-d61d94d78862)
- [Alcon Research, LLC](https://www.globalkeysolutions.net/companies/alcon-research-llc/3f7b4901-5f9f-4d4c-96ec-703f2ef5285b)
- [Precipart Corp](https://www.globalkeysolutions.net/companies/precipart-corp/23370f3c-d19d-4cd2-9369-c9c780b57c5a)
- [Stratus Pharmaceuticals Inc](https://www.globalkeysolutions.net/companies/stratus-pharmaceuticals-inc/b5f2695d-33d9-4bde-aad6-87b1466e9dc7)
- [Banjaras Inc](https://www.globalkeysolutions.net/companies/banjaras-inc/a70bf61e-a891-4717-aae4-5bb293df9ea9)
- [QPS, LLC](https://www.globalkeysolutions.net/companies/qps-llc/dd921aef-3600-420b-b84d-512c0675e45e)
- [Green City Distribution](https://www.globalkeysolutions.net/companies/green-city-distribution/7b4cf3dc-8b8f-42d2-9559-6766a7ca8424)

## Related Officers

- [National Program Expert- Pharmacy Compounding](https://www.globalkeysolutions.net/people/lucila-b-nwatu/3d1c9670-8206-425c-bddd-32e395293042)
- [Matthew R. Clabeaux](https://www.globalkeysolutions.net/people/matthew-r-clabeaux/9acc9b47-4063-4582-ac9a-983a07079495)
- [Stryker, Regulatory Affairs](https://www.globalkeysolutions.net/people/gunneet-kaur/e2823ed9-44f2-4553-8984-895ef8c7eece)
